Physician profile
Sarah Tyson
NPI 1548662323
$1,210.49
in general payments reported to CMS, 2019-2025
18 companies · $59.08 in 2025
The $59.08 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $137 · 2021: $104 · 2022: $293 · 2023: $233 · 2024: $152 · 2025: $59.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $173.26 | 2019-2021 | |
| Alcon Vision LLC | $165.85 | 2022-2025 | Rocklatan, Total30 |
| Sun Pharmaceutical Industries INC. | $159.58 | 2019-2024 | |
| Bausch & Lomb Americas INC. | $114.90 | 2023-2024 | Miebo, Lotemax Sm, Vyzulta |
| Novartis Pharmaceuticals Corporation | $111.49 | 2019-2022 | |
| Oyster Point Pharma, INC. | $102.48 | 2022-2023 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $96.21 | 2022-2024 | Acthar |
| Kala Pharmaceuticals, INC. | $46.30 | 2021-2022 | |
| Abbvie INC. | $45.89 | 2022 | |
| Eyevance Pharmaceuticals LLC | $31.71 | 2019-2022 | |
| Thea Pharma INC. | $30.02 | 2023 | |
| Shire North American Group INC | $26.78 | 2019 | |
| Aerie Pharmaceuticals, INC. | $25.74 | 2019 | |
| Dompe US, INC. | $20.75 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $16.68 | 2023 | Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.97 | 2021 | |
| Glaukos Corporation | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Tyson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.